Interaction of Pdcd4 with eIF4E inhibits the metastatic potential of hepatocellular carcinoma.

Oxidative stress can contribute to the development of hepatocellular carcinoma (HCC) ability of the carcinoma. It has been found that oxidative stress stimulates the phosphorylation of eIF4E primarily through mitogen-activated protein kinase (MAPK) pathways resulting in increased protein translation. Utilizing specific inhibitors of MAPK pathways (SP600125 for c-Jun amino-terminal kinases [JNKs], PD098059 for extracellular signal-regulated kinases [ERKs], and SB203580 for p38 MAPK), we determined that it is primarily the inhibition of JNK that results in the suppression of the increase of p-eIF4E. We also found that PDCD4 inhibits JNK activity resulting in inhibition of the phosphorylation of c-Jun, one isoform of AP-1. We demonstrated that transfection with PDCD4 or inhibition of JNK by SP600125 alters the expression and phosphorylation of eIF4E in the presence of H(2)O(2). PDCD4 results in a stronger inhibitory effect than SP600125.

[1]  Jonathan A. Cooper,et al.  The Phosphorylation of Eukaryotic Initiation Factor eIF4E in Response to Phorbol Esters, Cell Stresses, and Cytokines Is Mediated by Distinct MAP Kinase Pathways* , 1998, The Journal of Biological Chemistry.

[2]  A. Siddiqui,et al.  Hepatitis C Virus (HCV) Constitutively Activates STAT-3 via Oxidative Stress: Role of STAT-3 in HCV Replication , 2005, Journal of Virology.

[3]  C. McClain,et al.  A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. , 2003, The American journal of pathology.

[4]  N. Colburn,et al.  Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. , 2005, Cancer research.

[5]  Jiri Petrak,et al.  Proteomic analysis of iron overload in human hepatoma cells. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[6]  N. Colburn,et al.  Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. , 2004, Molecular cancer therapeutics.

[7]  A. Gingras,et al.  The mRNA 5' cap-binding protein eIF4E and control of cell growth. , 1998, Current opinion in cell biology.

[8]  S. Zimmer,et al.  Oxidant-induced hypertrophy of A549 cells is accompanied by alterations in eukaryotic translation initiation factor 4E and 4E-binding protein-1. , 2002, American journal of respiratory cell and molecular biology.

[9]  L. McKendrick,et al.  Involvement of Stress-activated Protein Kinase and p38/RK Mitogen-activated Protein Kinase Signaling Pathways in the Enhanced Phosphorylation of Initiation Factor 4E in NIH 3T3 Cells* , 1997, The Journal of Biological Chemistry.

[10]  Hiroki Tanaka,et al.  The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells. , 2006, The American journal of pathology.

[11]  N. Colburn,et al.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Nahum Sonenberg,et al.  A Novel Function of the MA-3 Domains in Transformation and Translation Suppressor Pdcd4 Is Essential for Its Binding to Eukaryotic Translation Initiation Factor 4A , 2004, Molecular and Cellular Biology.

[13]  J. Ou,et al.  Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[14]  Shelly C. Lu,et al.  Current Concepts in the Pathogenesis of Alcoholic Liver Injury , 2022 .

[15]  G. Mantovani,et al.  Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  H. Gram,et al.  Negative Regulation of Protein Translation by Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 , 2001, Molecular and Cellular Biology.

[17]  A. Wlodawer,et al.  Structural Basis for Inhibition of Translation by the Tumor Suppressor Pdcd4 , 2006, Molecular and Cellular Biology.

[18]  P. Angulo,et al.  Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.

[19]  N. Colburn,et al.  Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion , 2006, Molecular and Cellular Biology.

[20]  Y. Pekarsky,et al.  Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. , 2005, Cancer research.

[21]  G. Rao.  Oxidant Stress Stimulates Phosphorylation of eIF4E without an Effect on Global Protein Synthesis in Smooth Muscle Cells , 2000, The Journal of Biological Chemistry.

[22]  R. Cherla,et al.  Shiga toxin 1‐induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage‐like THP‐1 cell line , 2006, Journal of leukocyte biology.

[23]  L. Loeb,et al.  Reactive oxygen species in tumorigenesis. , 1994, Cancer research.

[24]  K. Lindor,et al.  Nonalcoholic fatty liver disease , 2005, Canadian Medical Association Journal.

[25]  R. Rhoads,et al.  Mapping of Functional Domains in Eukaryotic Protein Synthesis Initiation Factor 4G (eIF4G) with Picornaviral Proteases , 1995, The Journal of Biological Chemistry.

[26]  N. Sonenberg,et al.  The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation , 2003, Molecular and Cellular Biology.

[27]  Michele Pagano,et al.  S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth , 2006, Science.

[28]  M. Lai,et al.  Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. , 2004, Carcinogenesis.

[29]  J. Freedman,et al.  Copper-inducible transcription: regulation by metal- and oxidative stress-responsive pathways. , 2004, American journal of physiology. Cell physiology.

[30]  K. Klempnauer,et al.  Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun , 2004, Oncogene.